Beta-blockers in atrial fibrillation—trying to make sense of unsettling results
Markus Meyer, Daniel L. Lustgarten
Abstract
Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.
Topics & Concepts
Atrial fibrillationCardiologyBETA (programming language)Internal medicineMedicineFibrillationCardiomyopathyTachycardiaHeart failureComputer scienceProgramming languageAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Arrhythmias and Treatments